Specifically targeted gene therapy for small-cell lung cancer
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
http://www.tandfonline.com/doi/pdf/10.1586/era.09.10
Reference150 articles.
1. Chemotherapy for Relapsed Small Cell Lung Cancer: A Systematic Review and Practice Guideline
2. Recent advances in management of small-cell lung cancer
3. Small Cell Lung Cancer: Have We Made Any Progress Over the Last 25 Years?
4. China approves first gene therapy
5. Current Status of Gendicine in China: Recombinant Human Ad-p53 Agent for Treatment of Cancers
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In silico and in vitro investigation of dual targeting Prima-1MET as precision therapeutic against lungs cancer;Journal of Biomolecular Structure and Dynamics;2023-06-05
2. The Double-Edged Sword of SIRT3 in Cancer and Its Therapeutic Applications;Frontiers in Pharmacology;2022-04-27
3. Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer;Journal of Drug Targeting;2020-07-28
4. SIRT3 increases cisplatin sensitivity of small-cell lung cancer through apoptosis;Gene;2020-06
5. Dual Effect of Glucocorticoid-Induced Tumor Necrosis Factor–Related Receptor Ligand Carrying Mesenchymal Stromal Cells on Small Cell Lung Cancer: A Preliminary in vitro Study;Cytotherapy;2018-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3